Healthcare -
Biotechnology - NASDAQ - US
$ 55.26
9.27 %
$ 4.36 B
Market Cap
-11.68
P/E
Price Target
Average
--22.64%
Revenue Forecast
Estimate
6.64%
EBIT
Estimate
--35.18%
Net Income
Estimate
57.78%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
PTC Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for PTCT of $42.8 , with forecasts ranging from
a
low of
$30 to a high of $58 .
PTCT Lowest Price Target
Wall Street Target
30 USD
-45.71%
PTCT Average Price Target
Wall Street Target
42.8 USD
-22.64%
PTCT Highest Price Target
Wall Street Target
58 USD
4.96%
REVENUE FORECAST
Revenue Forecast Chart PTCT
EBIT FORECAST
EBIT Forecast Chart PTCT
NET INCOME FORECAST
Net Income Chart PTCT